Jafron Biomedical Co.,Ltd.

Equities

300529

CNE100002995

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
27.54 ^CNY	+1.62%		+20.79%	+23.89%

Apr. 26	Jafron Biomedical Co.,Ltd. Proposes Final Dividend for the Year 2023	CI
Apr. 25	Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.

April 03, 2024 at 08:18 am EDT

From April 1, 2024 to April 3, 2024, the company has repurchased 6,479,843 shares, representing 0.8% for CNY 154.55 million. With this, the company has completed the repurchase of 24,242,904 shares, representing 3% for CNY 500 million under the buyback announced on July 17, 2023.

Latest news about Jafron Biomedical Co.,Ltd.

Jafron Biomedical Co.,Ltd. Proposes Final Dividend for the Year 2023	Apr. 26	CI
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.	Apr. 03	CI
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.	Apr. 03	CI
Jafron Biomedical Co.,Ltd.'s Equity Buyback announced on July 17, 2023, has closed with 24,242,904 shares, representing 3% for CNY 500 million.	Apr. 02	CI
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.	Jan. 02	CI
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Zhuhai Jianfu Pharmaceutical Co., Ltd. announced that it expects to receive CNY 15 million in funding from Jafron Biomedical Co.,Ltd.	23-10-22	CI
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.	23-10-12	CI
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-18	CI
Jafron Biomedical Co.,Ltd. announces an Equity Buyback for CNY 500 million worth of its shares.	23-07-17	CI
Jafron Biomedical Co.,Ltd. authorizes a Buyback Plan.	23-07-16	CI
Jafron Biomedical Co.,Ltd. Announces Cash Dividend on A Shares for the Year 2022, Payable on 31 May 2023	23-05-24	CI
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Jafron Biomedical Co.,Ltd. Approves the Cash Dividend for 2022	23-04-24	CI
Jafron Biomedical Co.,Ltd. Approves Director Elections	23-04-24	CI
Jafron Biomedical Co.,Ltd. Announces Profit Distribution Proposal for 2022	23-03-31	CI
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Jafron Biomedical Co.,Ltd. Implements Final Cash Dividend (A Shares) for 2021, Payable on 10 June 2022	22-06-05	CI
Jafron Biomedical Co.,Ltd. Approves Profit Distribution	22-05-16	CI
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-13	CI
Jafron Biomedical Boosts Final Dividend as 2021 Profit Surges 37%	22-04-13	MT
Jafron Biomedical Co.,Ltd. Announces the Profit Distribution Proposal for 2021	22-04-12	CI

Chart Jafron Biomedical Co.,Ltd.

Duration

Period

More charts

Company Profile

Jafron Biomedical Co.,Ltd. is a China-based company principally engaged in the research, design, manufacture and distribute of biological materials and medical equipment. The Companyâs products include disposable hemoperfusion devices, hemoperfusion machine, disposable bilirubin adsorbers, DX-10 blood purification machine, suture needle, as well as resins bandage, among others. The Companyâs products are applied in uremia, poisoning, severe liver diseases, autoimmune diseases, as well as multisystem organ failure, among others. The Companyâs products are applied in 31 provinces, more than 3000 hospitals in China.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-20 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Jafron Biomedical Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

27.54 CNY

Average target price

30.94 CNY

Spread / Average Target

+12.36%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
JAFRON BIOMEDICAL CO.,LTD.	+23.89%	2.95B
ABBOTT LABORATORIES	-3.77%	184B
MEDTRONIC PLC	-1.77%	107B
BECTON, DICKINSON AND COMPANY	-1.43%	67.52B
DEXCOM, INC.	+2.06%	50.06B
CENCORA, INC.	+9.43%	45.67B
HOYA CORPORATION	+3.40%	41B
METTLER-TOLEDO INTERNATIONAL, INC.	+3.04%	26.73B
WEST PHARMACEUTICAL SERVICES, INC.	+4.64%	26.47B
TERUMO CORPORATION	+15.23%	25.05B

Other Medical Equipment, Supplies & Distribution